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Lyme disease is the fastest growing vector-borne illness in the United States. Its causative factors, 
are the spirochetal bacterium Borrelia burgdorferi and its close relatives. Infection in humans hard 
to treat, and long term, or chronic, illness follows initial Borrelia infection approximately 20% of the 
time. Many sufferers turn to non-traditional methods of treatment. This study sought to identify and 
test natural products for anti-borrelial qualities, using anecdotal success as an initial filter. Thirty-
five herbal Lyme disease treatments were so identified. Extracts from these materials were made 
using three solvents, and tested against Borrelia burgdorferi. Anecdotal success proved to be an 
effective filter for Borrelia inhibition, allowing us to identify several extracts which inhibited its 
growth, and also several growth enhancers, each of which should be further investigated as 




















Abbreviations and Definitions 
 
ATP- adenosine triphosphate- energy currency of the cell 
BbGFP-test strain of Borrelia burgdorferi with GFP marker 
CDC- center for disease control 
EM- erythema migrans, the representative bulls-eye rash seen in 40% of Borrelia infections 
EPS- extracellular polymeric substances ( goo around biofilm) 
FlaB- core flagellar protein in Borrelia 
GFP- green fluorescent protein, a marker added via kanamycin-retained plasmid to allow detection via 
fluorescence readings 
GlcNAc - sugar, N-Acetyl Glucosamine 
IAFGP- ixodes antifreeze glycoprotein  
LPS-Liposaccharide component of some bacterial cell membranes 
MIC- minimum inhibitory concentration 
Negative control- area demonstrating unaltered natural growth of bacteria, for comparison 
OspA, Osp C- outer surface protein A, C, etc. 
PICC- peripherally inserted central catheter- line inserted in the brachial artery (upper arm) that extends to 
the heart and administers intravenous pharmaceuticals directly, for most effective full-body distribution . 
Positive control- area demonstrating killed or inhibited state using known compound, for comparison 
PTLDS-post treatment Lyme disease syndrome 













Background & Significance 
 
HISTORY AND DISTRIBUTION OF LYME DISEASE  
 Lyme disease is the fastest growing vector-borne illness in the temperate world, (figure 1a) with 822 
new cases every day and 300,000 new infections documented yearly in the U.S. alone (figure 1b) (CDC). In 
the United States, Lyme disease was ranked among the six most common Nationally Notifiable diseases by 
the Centers for Disease Control in 2015.  The geographic concentration of infection is notable, with 95% of 
new diagnoses originating from only 14 states (Connecticut, Delaware, Maine, Maryland, Massachusetts, 
Minnesota, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont, Virginia and 
Wisconsin) (CDC) (figure 1b). 
   
 Previously known as the summer flu for its initial flu-like symptoms, Lyme disease got its name 
from the Connecticut town where its causative factor, the spirochetal bacterium Borrelia burgdorferi, was 
first isolated by Dr. William Burgdorfer in 1982 (Steere et al., 1983). Despite recent attention stemming from 
pronounced increase in documented cases, the pathogen is neither new to humans, nor an American 
phenomenon. The earliest evidence of Borrelia infection comes from Ötzi, a 5300-year old ice mummy 
uncovered on the Tisenjoch Pass of the Italian Alps in 1991.  Otzi’s genome was sequenced in 2012, and 
among his cells, 60% of Borrelia’s genome was also found (Keller et al., 2012). It was the only pathogenic 
bacterium isolated from the mummy. 
 
	 7	
ECOLOGICAL PLAYERS  
 The geographical density and rampant spread of the disease becomes more understandable with 
knowledge of B. burgdorferi’s ecological niche. This etiologic factor is a fastidious, microaerophilic obligate 
parasite which has evolved a multi-host lifecycle of three main components: the bacterium, its vector the 
ixodes tick, and the biological reservoir, white footed mice (Radolf et al., 2012). There are additionally two 
notable ancillary participants: a vector maintenance species (deer) and accidental hosts (notably, humans and 
canines). 
 Because Borrelia is not able to survive naturally outside of a biological host, and is not transmitted 
via either mammalian or arachnid ova (Breuner et al., 2018), its population must continually be maintained 
across the arachnid and vertebrate hosts by blood transmission. Relying on differential gene expression to 
exist in the disparate physiological conditions of these animals, Borrelia travels via the bite of its primary 
vector, the hard-bodied ixodes tick.  These arachnids require a blood meal to molt or lay eggs, and it is 
through these blood meals that both the initial arachnid infection and later transmission to mammalian hosts 
are accomplished (figure 2a).  
  
 Borrelia’s absolute dependence on tick as vector means that its infection rates are tied to the life 
cycle of the vector species such that the acute Lyme disease infection rates correlate to both the 
environmental presence of nymphal ticks (figure 2b), and to the size and distribution of the infected tick 
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population as a whole. The warmer, wetter, environmental conditions afforded by climate change allow 
expansion of arthropod-friendly habitats(Ostfeld and Brunner, 2015), with the Center for Disease Control 
and Prevention estimating that at current rates of climate change, relevant tick habitats will increase 213% by 
the year 2080 (CDC). Further, as human civilization expands, overlap between our habitats and those of 
Borrelia’s biological vector leads to higher rates of human exposure and infection through proximity. 
 Another species relevant to Borrelia’s life-cycle is the white footed mouse (Peromyscus leucopus).  
As primary biological reservoir for the bacterium, the health and size of this small rodent’s population 
heavily impacts Lyme disease infection rates, demonstrating increase of new infections, for example, during 
years with an abundance of acorns, a primary calorie source of the reservoir species. Mice pose an especially 
significant problem for Borrelia control due to adaptive factors which make them an ideal reservoir.  
 The white footed mouse displays very little immune response to the bacterium (Ullmann et al., 2003)  
(figure 3a) , and therefore does not suffer from movement-inhibiting, pain-inducing inflammatory symptoms 
present in most other hosts.  Similar species, such as chipmunks and rabbits, transmit Borrelia at 50% the 
rate of white footed mice 
(figure 3b) within the same 
Lyme disease endemic habitats, 
despite similar phylogeny and 
food sources due to greater 
immune response. Because of 
their lack of humoral 
bacteriolysis, mice have a 
comparatively higher systemic 
infection level without 
significantly decreased 
locomotion or neurological 
involvement, making them ideal 
	 9	
biological reservoirs. In contrast, the bacterial dose required for severe symptomatology in humans is very 
low, at one bacterium per 10mL (Wolgemuth, 2016) with symptom-decreased mobility at a low bacterial 
load they offer no evolutionary benefit to the bacterium and are therefore characterized as incidental hosts.  
 Second, white footed mice derive specific benefit from their association with ticks: frostbite 
resistance. Feeding ticks contribute small amounts of ixodes antifreeze glycoprotein (IAFGP) to their host 
(Heisig et al., 2015; Neelakanta et al., 2010).  In sufficient concentration, accomplished with relative ease on 
small bodies with many ticks, this glycerol imparts protection to the white footed mice expanding its natural 
habitat, and making ticks desirable habitat partners. Nesting mice, in return, provide a target-rich 
environment of hosts for newly-hatched ticks.  
 This tripartite symbiosis between bacterium, biological vector and reservoir species is a primary 
factor in the spread of Lyme disease, but there are two relevant ancillary participants as well: deer and 
incidental hosts such as humans and canines. Deer are an essential part of the vector life-cycle, as the 
primary hosts for ixodes pre-ovulation blood meals (CDC)(figure 3a), but they are not carriers of Borrelia, 
demonstrating near one hundred percent immune kill rate of the bacterium in laboratory tests (figure 3c) 
(Ullmann et al., 2003). In the US distribution map (figure 1b), spread of Borrelia is slow- moving, perhaps, at 
the speed of mouse migration, instead of that of deer.  Transmission by deer would display wide, faster 
coverage, due to their broad and overlapping migratory routes.  Instead, deer support and transport the tick 
adults and are most often the source of the blood meal necessary to form eggs, but ticks feeding on deer 
become Borrelia free (Roome et al., 2017). This suggests that it may be evolutionarily beneficial to remove 
Borrelia as caloric competitors for egg production resources. Ticks return to mice and small rodents for the 
laying of eggs, and the larval ticks become infected with Borrelia from these mouse reservoirs. 
BORRELIA: BEHAVIOR, STRUCTURE AND EXPRESSION  
 Borrelia burgdorferi is one of many related spirochetal bacteria (Margos et al., 2018) with a 
multiple-host life cycle (figure 3a), truncated metabolism and plasmid-modified genetic profile (Casjens et 
al., 2017) comprised of a small linear chromosome containing 853 genes, and 17-22 relatively large linear 
and circular plasmids that contain additional information essential for virulence and infectivity (Kenedy et 
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al., 2012).  It is virulent and highly invasive (Aslam et al., 2017), and notoriously difficult to work with under 
lab conditions.  Its fastidiousness, slow-growth, microaerophilic requirements, and genetic intractability, 
represent mechanisms unique in the known world (Troxell et al., 2012), and  there is a growing library of 
research devoted to deciphering its secrets.  
Membrane strategies  
 Categorized as gram-negative-similar, due to its diderm structure but lack of gram-negative-
characteristic external liposaccharide proteins, Borrelia’s external membrane is resistant to polar compound 
intrusion, helping it to resist many antibiotic compounds (Scorciapino et al., 2017). The membrane also 
provides more specific immune protection imparted by its multi-host adaptation, in the form of differential 
expression, antigen switching, and hiding of intrinsic proteins  
 Immune response often relies on recognition of external proteins, and therefore control of protein 
exposure is a potent immune-evasive adaptation. In Borrelia, protein expression is controlled by the Rrp2-
RpoN-RpoS regulatory pathway, and triggered by environment, specifically the ixodes blood meal 
(Groshong and Blevins, 2014). Outer surface 
protein C (OspC) is a primary indicator of 
mammalian Borrelia infection, while Outer surface 
protein A (OspA) is expressed primarily in arachnid 
hosts (Kenedy et al., 2012). As central regulator of 
this pathway, and therefore of differential protein 
expression necessary for transfer and survival 
between arthropod and mammalian hosts, RpoS 
mediates the OspA/OspC balance to optimize 
infection, dissemination and bacterial survival 
(Yang et al., 2003). 
 Because these externally expressed proteins 
are strongly immunogenic, provoking a hearty immune response at very low concentration once recognized 
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by the body, Borrelia burgdorferi has evolved an elegant immune evasive solution. The external membrane 
varies presentation of immune-exposed proteins to reduce antibody formation.  This antigen switching, 
moves specific surface-exposed lipoproteins-targeted to the external leaflet by default after translation- to a 
secondary location within the bacterial periplasm (Hyde, 2017). The behavior relocation is based on 
sequence-specific signals (Schulze and Zuckert, 2006) and renders  the proteins invisible to the immune 
system. Additionally, several plasmids have been found to be responsible for outer surface protein 
production, presenting a huge, and ever-new array of membrane proteins to foil immune recognition (Cullen 
et al., 2004). The variety and rotation of membrane-presented proteins makes antigen testing for Lyme 
disease diagnosis problematic. 
Another way in which Borrelia uses its outer membrane to guard against immune response is purely 
structural: it expresses certain essential proteins (notably the flagella) only within the periplasmic space 
(figure 5). As opposed to the external flagella present in most known prokaryotes, B. Burgdorferi has 7-12 
periplasmic flagella between the cell body and outer 
membrane which confer both its distinctive spiral 
shape and eukaryote-similar flat-wave movement 
patterns(Motaleb et al., 2000).  Mutants deficient in 
Fla-B (a structural flagellar protein) are both non-
motile and non-spiral, confirming this relationship 
(Wolgemuth et al., 2006). 
Nutrient use: 
 During infection and dissemination in a mammalian 
host, flagella impart both directional control, and 
velocity: allowing the spirochete to exceed the speed of 
neutrophils, the fastest human immune cell, by 2 orders 
of magnitude and making them an important, and 
effective, part of the bacterium’s infective cycle 
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(Malawista and de Boisfleury Chevance, 2008)However, this speed has a cost, and flagellar motors are 
nutrient-greedy, high consumers of ATP. To feed this need, the fastidious Borrelia has only seven carbon 
sources: Glucose, GlcNAc, glycerol, chitoboise, trehalose, mannose and maltose, and shows preferential use 
of glucose due to several transport shortcuts which make it the least resource-intensive to metabolize (Troy et 
al., 2016; Vechtova et al., 2018)  
 The bacterium travels optimally in the structure and resistance of extra-cellular matrix material 
which informs laboratory use of semisolid media during cultivation(Harman et al., 2012).  N-Acetyl 
Glucosamine (GlcNAc), which comprises the majority of this matrix in mammals, is not only one of the 
seven carbon sources used by Borrelia for metabolic purposes, it also acts as a chemoattractant (Bakker et 
al., 2007) and may be a factor in sequestration in GlcNAc -rich cartilaginous sites.  
 Borrelia lacks coding for the enzymes necessary for full aerobic metabolism and does not possess 
the ability to perform a TCA cycle, oxidative phosphorylation, or electron transport (Corona and Schwartz, 
2015). It relies solely on glycolysis and abundant host resources for ATP production, and has limited 
biosynthetic capability, with no complete pathways for de novo synthesis of fatty acids, amino acids, 
nucleotides, or co-factors, and relying instead on multiple and redundant transport proteins for various 
nutrients and cofactors, making it an obligate parasite (von Lackum and Stevenson, 2005). 
 The microbe’s host-specific behaviors are controlled by the presence of host-specific nutrients and 
environmental conditions which in turn govern gene expression, viability, and movement. The bacterium’s 
complicated life cycle and condensed genome force it to rely on different carbon sources in each host, and it 
exhibits host-specific morphologies and protein expression seemingly tied to this reliance (Steere et al., 
1983).  
 The bacterium’s paucity of metabolic machinery shows in several essential ways: first, in speed of 
growth. Due to its sole reliance on glycolysis for ATP (Corona and Schwartz, 2015; von Lackum and 
Stevenson, 2005). Borrelia grows very slowly- with a generation of 12-24 hours. This makes cultivation and 
treatment challenging for both temporal reasons, as duration of single test growth is 2 weeks, and also for 
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reasons of contamination, because short-generation contaminants, if present, will out-grow and out-compete 
Borrelia in the very rich media it requires.  
 Metabolic limitations are also displayed in behavior: two of its seven carbon sources (glucose and 
GlcNAc) are strong chemoattractants, inducing migration; and a preponderance of a third (glycerol) triggers 
a semi-dormant state of low movement and reproduction. This stillness is exhibited in the hemolymph, or 
gut, of an unfed arachnid seemingly because 3carbon glycerol, the most abundant nutrient in that habitat, 
does not provide enough ATP for the energy-expensive flagellar motors to be fully active. The unfed tick 
midgut is oxygen-poor, cold and alkaline.  This condition persists until one of three post-infective 
bloodmeals is taken by the arachnid host.  Once a blood meal is taken, the increase in nutrients, temperature, 
acidity, cell density and oxygenation activate chemotaxis and differential expression of external proteins 
(Caimano et al., 2016). These environmental changes trigger the primary regulatory pathway(Rrp2-RpoN-
RpoS), which signals outer surface protein activation/repression (Sapi et al., 2016) and other differentially 
expressed proteins allow binding of plasminogen activators present in the mammalian blood, and production 
of proteolytic plasmin which allows migration through the tick endothelium to the salivary glands for 
injection into the mammal host during feeding (Carroll et al., 1999; Coleman et al., 1997) change and transit 
takes some hours after exposure to mammalian blood, after which point Borrelia may be transmitted to a 
mammalian host. After 6 hours 4%,12 hours 10% and after 4 days of attachment there is 100% probability of 
Borrelia transmission from an infected tick (CDC). 
 In the salivary glands, Borrelia binds immunosuppressant salp15 protein found in tick saliva, to 
inhibit T-cell activation in mammals and facilitate early migration, and in the nutrient-rich mammalian host, 
it again expresses lytic complement complexes which aid in immune evasion by extracellular matrix 
degradation (Kurtenbach et al., 2002) during flagellar travel.  
 Once in the mammal, spirochetes are able to disseminate quickly, moving to immune-deficient 
compartments such as joints before immune cells can capture them, (Malawista and de Boisfleury Chevance, 
2008) and, in some cases, an autoimmune effect occurs, and the patient’s own immune system joins 
Borrelia’s degradation of the extra-cellular matrix, destroying tissue.   
	 14	
DISEASE AND TREATMENT  
 Borrelia burgdorferi infection in humans is responsible for an array of symptoms from fever to 
palsy, including paralysis, cognitive impairment, and unremitting pain. Due to the constellation of symptoms, 
Lyme disease is often misdiagnosed as fibromyalgia, lupus, stroke, depression, schizophrenia, and any 
number of minor ailments (Berndtson, 2013). This shared symptomology has prompted medical 
professionals to dub Lyme disease “The great imitator” (a nickname previously used for syphilis- also caused 
by a spirochete). Combined with the low bacterial load necessary for significant illness and poor antibody 
testing, this confusion has proven an impediment to timely treatment.  
 Diagnosis of borreliosis based on either symptoms or serology has proven difficult. 
Clinical diagnosis of Lyme disease is based on four primary acute infection symptoms. 1. Erythema migrans, 
or bullseye rash (Chaaya et al., 2016) which is exhibited by less than 40% of infected humans and indicates 
cutaneous dissemination. 2. knee effusion- a symptom of immune response to hiding spirochetes in the 
cartilaginous knee which indicates humoral dissemination 3. Bell’s palsy -paralyzation of half of the face 
which indicates neurological dissemination or 4. or a positive antibody test demonstrating an immune 
response to 3 or more specific Borrelia proteins, whose problematic nature we have already discussed 
(Dessau et al., 2018).  
  Even after diagnosis, treatment of the disease is not straightforward. Oral doxycycline, a protein 
synthesis inhibitor which is Borrelia-static, rather than borreliacidal, can be effective very early in the acute 
infection stage (previous to sequestration or neurological involvement), but disseminated Borrelia cannot be 
cleared in this way. The spirochete’s sequestration behavior requires widespread minimum inhibitory 
concentration (MIC) of effective anti-Borrelia antibiotics in all compartments (intra as well as inter cellular, 
vascular as well as a-vascular, and both sides of the blood/brain barrier in cases with neurological 
involvement). This is difficult because dosing required to reach intracellular MIC of pharmaceuticals can 
result in toxic serum levels. Additionally, Borrelia’s lengthy12-24 hour generation time complicates 
treatments that rely on drug density during reproduction, as it is difficult to maintain sufficient and constant 
blood and tissue concentration for the multiple generation periods necessary to address an active infection. 
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And finally, although Borrelia can (and does) cross the blood/brain barrier to provoke severe neurological 
symptoms (Ramesh et al., 2003) not all commonly used pharmaceutical can- which limits drug choice.  
 Even in the face of what is thought to be appropriate antibiotic treatment, around 20% of cases still 
experience disease progression and long-term illness (CDC). Continued illness seems to depend to some 
extent on individual immunity, and some early infections don’t show the specific hallmark symptoms 
associated with Lyme disease, instead 
presenting as flu-like symptoms, 
muscle cramps or migraine headaches 
and remaining untreated until more 
serious signs emerge. However, later 
illness is often much more pronounced 
and characterized by ongoing 
exhaustion, pain, cognitive 
impairment, autoimmune symptoms, 
metabolic disruption, psychological 
symptoms, (Ramesh et al., 2003)and later, related, diagnoses including lupus, sarcoidosis, Alzheimer’s 
disease, multiple sclerosis, non-Hodgkin’s lymphoma and glioblastoma.(Schollkopf et al., 2008) 
 One school of thought holds that continued or relapsing illness after Borrelia infection is due to 
insufficient eradication of the spirochete. This is often referred to as Chronic Lyme disease, because it is 
believed to result from a remaining pathogenic presence. It is treated by medical practitioners with a variety 
of traditional antibiotics, either alone or in combination, and often for much longer courses than otherwise 
normally administered. One commonly used drug is PICC-administered intravenous Ceftriaxone - a cell wall 
inhibitor with a long half-life- which attempts to maintain MIC both temporally and compartmentally via 
administration directly to the heart. Accurate diagnoses of Chronic infection are complicated by the low 
bacterial load required for significant illness, and difficulties in isolating extant spirochetes from these 
patients. 
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Survival morphologies  
 Though decorin binding, and tissue sequestration allow the bacterium to establish persistent infection 
even in the presence of a strong immune response (Sellati et al., 1996) the spirochete seeks to disseminate 
beyond the initial infection site quickly to colonize secondary immune-secluded sites such as joints and 
central nervous system. The bacterium can hide in tissues less available to humoral immune response such as 
the central nervous system and cartilaginous sites, limiting drug and immune access in low circulation areas, 
and sometimes inducing auto-immune attack within the host In addition to reducing antibiotic and immune 
access, this potentially provides an internal reservoir of infection (Groshong and Blevins, 2014; Hyde, 2017) 
 For instance, persistor cells are individual cells which appear identical to their population, but have 
one important difference: they reproduce on a different schedule. Since antibiotic compounds kill primarily 
during reproductive cycles, being off-cycle can have a protective advantage. It is important to note that these 
are individual cells, not full clonal lines, and that they seem genetically identical to their sister cells, 
meaning, these cells are not antibiotic-induced mutants, but a naturally-occurring portion of the population 
which confer resistance to pharmaceutical treatments through dormancy and regeneration. This delayed 
reproductive behavior has been documented in many bacteria, and seems to be related to ATP use (Sharma et 
al., 2015)  
 Borrelia also seems to persist in the face of high-stress environments such as antibiotic pressure and 
low nutrient availability is by encapsulation- having been documented to form round bodies, also called cell-
wall deficient, or cystic forms.  These cysts contain spirochetes within a glycolic boundary not susceptible to 
traditional antibacterial 
medications (figure 7). While 
thus invulnerable to antibiotics, 
the spirochetes multiply, 
representing a protected mini-
reservoir of bacteria (Vancova et 
al, 2017). Cycling different 
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antibiotics, or timed antibiotic hiatus are used by some physicians to address this survival technique, and 
some studies have shown success with anti-parasitic drugs used against round bodies. 
 The final documented survival morphology 
Borrelia is known to enlist, is biofilm Sapi et al., 2012) 
(figure 8).  This multi-layered microbial community 
contains many organisms and cofactors surrounded by a 
matrix of extracellular polymeric substances which inhibit 
access for outside attack by either host immune response 
or medication Biofilm communities represent a protective 
environment for bacterial propagation and a possible 
internal bacterial reservoir, impervious to many 
pharmaceutical treatments.        
Alternative hypothesis for post-treatment illness      
 Though many believe persistent infection is the cause of continued illness after Borrelia exposure, 
others hypothesize changes made to the host system by the bacteria and/or the treatments are behind 
persistent symptoms.  They call this continued illness Post treatment Lyme disease Syndrome, or PTLDS. 
There can be some overlap with Chronic Lyme disease theories, as PTLDS does not rule out the continued 
presence of Borrelia in some form, it just posits a systemic change instigated by the combination of Borrelia 
and/or its treatment.  Suggested possible causes for this systemic change include epigenetic switching 
(turning on, or off specific genes linked to the symptoms), lasting damage due to the burrowing of Borrelia 
into body compartments such as the blood/brain barrier, gut endothelium, pericardium, or cartilage; and 
microbiome disruption from antibiotic killing of important commensal bacteria- resulting in dysbiosis and 
severe health imbalances. 
What is being done?  
 Many effective pre-infection measures are being pursued to kill Borrelia before it reaches its 
accidental human hosts. Habitat treatments such as bait stations containing insecticidal food or bedding 
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materials for mice, or genetic alteration of mice to reduce their viability as reservoirs (Buchthal et al., 2019) 
are being actively pursued. Attempts to create an effective vaccine against Borrelia have so far fallen victim 
to its biochemical sleight of hand. Outer membrane proteins were early identified as good vaccine target 
prospects (Luft et al., 2002), and the original LymeRix vaccine was targeted specifically against OspA, a 
membrane protein upregulated in the arthropod host with the intent of teaching our immune system to 
destroy pre-dissemination spirochetes. Unfortunately, the speed of spirochete sequestration led to 
autoimmune attack on infected cartilage and heart tissue in some patients and the LymeRix vaccine was 
removed from the market (Nigrovic and Thompson, 2007).  
 Recent advances have allowed the construction of a novel chimeric protein composed of epitopes 
from the most common OspC variants in canines. Immune response to each of the epitopes in the constructed 
antigen seems to confer specific antibody production sufficient to counter initial infections (Schreterova et 
al., 2017).  This new protein forms the basis of an effective canine vaccine which is being studied for 
adaptation both in human vaccines, and diagnostic immune assays.  
 However, even without new infections, there remains a significant reservoir of illness that must be 
addressed, so approaches able to treat existing infections are in high demand. A primary goal in this search is 
finding Borrelia-specific compounds that will kill or immobilize the spirochete without damaging the host 
microbiome.  Possible methods include targeting the bacterium based on Borrelia-unique characteristics, or 
interfering with mobility or antigen switching to allow clearance by the host immune system. 
 Once the drug is delivered to the spirochete, however, it must still enter the cell. These ancient 
bacteria are evolved to exclude compounds dangerous to them, with an outer membrane effective at 
excluding hydrophilic compounds, and an inner membranes capable of excluding most hydrophobic 
compounds. Richter, et al, use broad-scale testing and characterization to find patterns in compounds 
successful against gram negative bacteria. They include: compound must be small, flat, inflexible, contain a 





 During the 1950s, known pathogens were extensively tested against natural products, whose 
antimicrobial compounds are evolutionarily optimized for bacterial penetration and seemed a promising 
source of new antibiotic medications. But Borrelia was not isolated until 1981 (Steere et al., 1983) and 
therefore it was not tested as fully against naturally-occurring compounds as many earlier-discovered 
pathogens, leaving a target-rich environment. 
 Due to the difficulty in getting conclusive medical solutions to Lyme disease related illness, patients 
often seek treatment from less scientific sources. One common path is to use traditional medicine and herbal 
supplements. Many sufferers believe that these treatments are effective and report significant positive result 
during their use. In the context of previous natural antibiotic source, we chose to use anecdotal success of 
herbal treatments for Lyme disease as an initial selection filter to choose natural products we wish to screen 




 Specific Aims: 
 In order to test my hypothesis, I propose the following  
Aim #1 
Identify effective approaches to test and detect efficacy of compounds against 
Borrelia burgdorferi in vitro. 
Aim #2 
 Review potential natural producers of anti-Borrelia compounds from anecdotally 
effective Lyme disease treatments and extract natural product constituents based on 
their polarity.   
Aim #3 
Test extracts against Borrelia, and test effective anti-Borrelia compounds for 












 Non-pharmaceutical plant products were chosen and tested for inhibition of GFP-tagged Borrelia 
burgdorferi based on their use and anecdotal success as Lyme disease treatments. For purposes of selection, 
internet sites and natural medicine protocols were used to identify herbal products suggested for Lyme 
disease treatment. Plant products identified as part of treatments with multiple anecdotal successes, which 
were found in more than one reference location, were chosen to test. This resulted in a list of 31 plant 
products.  
 Two plant-based products previously identified in scientific literature as Borrelia inhibiting (stevia 
and monolaurin) (Goc et al., 2017) (Theophilus et al., 2015) and one animal-based product (bee venom) 
(Socarras et al., 2017)were chosen as internal positive controls. Two plant products (dandelion and nettle) 
were included for investigation due to their status as preferential fodder for Borrelia-resistant deer.  All test 
compounds were acquired according to Table 1. 
Extract preparation 
 Extractions were performed on whole plant products, left un-sterilized to allow for plant-native 
bacterial populations which might be responsible for their anecdotal effectiveness, and conducted in a fume 
hood, at room temperature, using each of three solvents. Non-sequential extractions were performed on each 
vegetative product, with water, methanol, and hexanes to maximize compound extraction. 20mL of sterile 
deionized water, 0.2 micron filtered HPLC grade methanol (Fisher Chemical A452-4), or Fisher Chemical 
hexanes, methylpentanes 4.2%, (Fischer Chemical H292-4) were used as solvents to access polar, semi polar, 
and non-polar compounds. In glass tubes, 1 fresh gram of each plant material was soaked under agitation on 
a VWR standard analog shaker, shake level 4. After 24 hours, free solvent was removed, reserved, and 20mL 
fresh solvent was added to the same plant materials for 36 hours.  
 The two extractions were combined for each sample, and reduced to complete extract. Water 
supernatants were frozen on an angle to facilitate sublimation, and lyophilized to complete extract using a 
Freezmobile 25 EL lyophilizer.  Methanol and hexanes solutions were evaporated to complete extract, at 
room temperature in fume hood. For testing, each sample was re-suspended with 4mL of its original solvent 
(10x concentration) and sonication was used to aid dissolution where necessary. 
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Bee Venom Collection: 
 Bees were donated by Noah Wilson-Rich of Boston Best Bees, Boston, MA and cooled to 4°C to 
produce stupor. It was necessary to remove venom sacs whole to eliminate contamination by body 
compounds known to be bacteriostatic. While cooled, bees were placed on an ice-filled platform of a 
stereoscope and decapitated before removing the venom sac with tweezers. Intact venom sacs were frozen at 
-80°C for storage. Photos were taken on Nikon smz800, level 3, 30xmagnification (figure 9). 
 
Preparation of extracts for liquid and semi-solid testing of Borrelia growth inhibition  
 For solid plating, methanol and hexane extracts only were used. Whatman grade AA 6mm paper 
inhibition discs were sterilized via UV exposure. 20µL of each resolubilized extract, or control solvent, was 
applied to individual discs and allowed to evaporate for 1 hour in a biosafety hood. Discs were stored, sealed, 
at room temperature for 4 weeks before plating in novel lawn-alternative method. 
 For liquid plating, 3 µL of each 10x concentrated extract or control solvent were placed in individual 
wells of 96well plates and evaporated in a biosafety cabinet for 1hour at room temperature.  
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BORRELIA GROWTH 
Table 2- strains and media employed (Samuels, 1995 )  
Initial Borrelia semi-solid growth curve 
 Low passage isolates of B. burgdorferi strain B31 with an added GFP and flaB non-motile mutant B. 
burgdorferi were cultured in 5mL Barbour-Stoner-Kelly II (BSK-II) media (Sigma, St Louis, MO) 
supplemented with 6% rabbit serum and kanamycin at 100uL/mL and gentamycin 50uL/mL in GFP strains 
to maintain the plasmid containing the GFP cassette. Cultures were maintained in sterile 15 ml tubes and 
incubated at 34 °C with 5% CO2, 3%O2, and 13% relative humidity (Coy hypoxic glove box) for 6 days.  
 Spirochetes were counted by eye using three 6µL samples of each starting culture, wet-mounted on 
glass slides with cover slips via black field microscopy, Three fields each for each sample were counted, and 
the field counts were averaged. The starting culture was diluted to 1.00X103 spirochetes per mL with fresh 
BSK-II amended liquid media, and incubated in coy hypoxic glove box at 5%CO2, 3%O2, 34°C, and 13% 
relative humidity for 10 days. 
 24 hours after the second inoculation, and repeating every 24 hours for 10 days, 6µL diluted culture 
was placed between 2x 2mL layers of BSK-II amended media containing 7% gelatin and 1.7% Agarose 
(SeaKem) on 6 well cell culture plates. For each time point, undiluted initial culture as positive control, 
media-only negative control, and three culture dilutions in triplicate, were plated. Plates were sealed and 
incubated at 34 °C with 5% CO2, 3%O2, and 13% relative humidity (Coy hypoxic glove box).  All plates 
were counted for CFU by naked eye 10 days post-plating and the triplicate daily counts were averaged. 
Testing growth effects of herbal extracts using novel lawn-alternative semi-solid plating Method 
 2mL layer of Borrelia-amended BSK-II semi-solid media was poured into 6-well cell  
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culture plates, and visually divided in three areas (figure 10).  A 6mm inhibition disc soaked with plant 
extractions of either methanol or hexanes, or a control, was allowed to evaporate solvent under a fume hood, 
then place in a labelled plate area. Six microliters of 1.00X106 spirochetes per mL Borrelia inoculate were 
administered to the center of each plate. A covering layer of 2mL semi-solid BSK-II Borrelia-amended agar 
was then poured over disc and inoculate layer 
and plates were sealed with parafilm M and 
incubated at 34°C with 5% CO2, 3%O2, and 
13% relative humidity (Coy hypoxic glove 
box) for 10 days. Plates were photographed on 
Bio rad chemi-doc MP fluorescent imaging 
system at 532excitation/528emission with 
.05sec exposure time, false-color green images produced, and also at room conditions with a camera phone. 
Inhibition was read by eye, as zones of inhibition.  
Testing growth effects of herbal extracts using liquid plating 
 Low passage isolates of B. burgdorferi strain B31 with an added GFP, were cultured by inoculating 
5mL Barbour-Stoner-Kelly II (BSK-II) media (Sigma, St Louis, MO) supplemented with 6% rabbit serum 
and kanamycin at 100uL/mL, and gentamycin 50uL/mL to retain the GFP plasmid. Cultures were maintained 
in sterile 15 ml tubes and incubated at 34 °C with 5% CO2, 3%O2, and 13% relative humidity (Coy hypoxic 
glove box) for 6 days.  
 Spirochetes were counted by eye using three 6µL samples of each starting culture, wet-mounted on 
glass slides with cover slips via black field microscopy. Three fields each for each sample were counted, and 
the field counts were averaged. The starting culture was diluted to 1.00X103 spirochetes per mL with fresh 
BSK-II Borrelia-amended liquid media.  
  
solvent	
name 1 2 3 4 5 6 7 8 9 10 11 12
A 2 3 4 5 6 7 8 9 10 11 12 13
B 14 15 16 17 18 20 21 23 24 25 26 27
C 28 29 30 31 32 33 34 35 Bb only Bb+ abx empty media only
D 0 0 0 0 0 0 0 0 0 0 0 0
E 2 3 4 5 6 7 8 9 10 11 12 13
F 14 15 16 17 18 20 21 23 24 25 26 27
G 28 29 30 31 32 33 34 35 Bb only Bb+ abx empty media only
H 0 0 0 0 0 0 0 0 0 0 0 0
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200µL of this inoculate was added to each well of 96well plate containing solvent-evaporated test 
compounds, and to wells for positive growth control, and antibiotic kill control. Media without inoculate was 
added to one well as a media control, according to the following plate map: 
 Plating was performed in duplicate, using 1x96-well plate per solvent. Plates were sealed using 
parafilm M and incubated in microaerophilic chamber, for 10 days, then and read for fluorescence on an 
electronic plate reader, using GFP settings: 532excitation/528emission. Change in growth from GFP-tagged 
B.burgdorferi negative control was calculated via: [extract well growth minus negative control)/ Negative 
control] This calculation yielded percent difference from normal growth, with valence. 
 
Counter-testing pathogenic lawns: 
 In order to test the compounds for 
specificity against Borrelia, gram 
positive (S.aureus) and gram negative 
(E.coli) were cultured by inoculating 
individual 5mL culture tubes 
containing Mueller Hinton II broth 
(MHB-II) liquid media with frozen 
E.coli strains MG1655 and WO153 
and S.aureus strain HG003 and 
incubated under agitation at 27°C for several hours to approximately 0.6 OD. OD was measured via  
spectrophotometer.  Cultures were diluted with MHB-II to 0.3 OD, and two Large rectangular plates per 
pathogen, containing 40mL Mueller Hinton II Agar (MHAII) were flooded with 40mL of either E.coli 
MG1655, attenuated E.coli WO153, or S.aureus HG003. Excess liquid was removed, and plates allowed to 
air dry in sterile hood. Plates were spotted with 3µL portions of the thirteen most active water-based extracts 
(methanol and hexanes extracts were not available) and incubated, without agitation, at 27°C for 24 hours. 




Extraction of bee venom 
 Due to previous findings of bee venom as an effective antimicrobial against Borrelia (Socarras, 
2017), this compound was selected for addition as a positive control. However, quantity of venom needed to 
reach MIC was 200 µL per test and the quantity of venom in each venom sac was 5m L, or less, not all sacs 
could be removed intact, and it involved killing the animal. It was therefore decided to halt collection after 
50 animals, as the ecological cost was prohibitive. Therefore, I did not test bee venom in the Borrelia growth 
inhibition assays as originally planned. 
 
Growth Curve Results: 
 In order to better understand Borrelia growth patterns, I performed a 10-day growth curve using both 
GFP-tagged B.burgdorferi and flaB B.burgdorferi, a non-motile mutant, in triplicate.  Data for flaB mutant 
was inconclusive due to early contamination, but the non-motile and no spread morphology were noted. The 
motile, GFP-labelled bacterium showed normal exponential and stationary phase transitions (Figure 14) and 
demonstrated migratory plate distribution rather than surface creep. Radial growth from the point of spotting, 
with regular areas of clonal clumping, 
rather than even, topical coverage was 
observed (not shown). Due to these 
growth characteristics, I designed a 
Figure 14 Growth curve for GFP-
tagged B.burgdorferi shows normal 
growth rate and phase transitions. 
In-vitro growth curves of GFP-tagged 
B.burgdorferi in solid Borrelia-
optimized colorimetric media 
incubated under microaerophilic 
conditions. Starting concentration of 
1.00X103 Counts of colony forming 
units at 36, 60, 84, 108, 132, 156, and 
180 hours were performed in triplicate 
and enumerated by eye after 10 days 
incubation and graphed on a 
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novel lawn-replacement plating method for compound testing as an alternative to traditional pathogenic lawn 
growth inhibition assays impossible with this organism.   
 
 
 Bacterial pathogens are commonly tested for antibiotic inhibition by creating agar-based solid media 
with an even, topical, bacterial growth called a lawn. The bacteria is then exposed to possible antibiotic 
substances via direct spotting of extract (figure 12), or using paper inhibition discs (figure 15a) soaked with 
the test compound. This is impossible with Borrelia which prefers to move through, rather than on, a semi-
solid matrix, and whose colony-formation is non-continuous.  evenly- creating discrete clonal colonies rather 
than continuous distribution. 
 
Figure 15: Novel semisolid plating method for growth inhibition of GFP-tagged B.burgdorferi in. a. 
Representative extract-soaked diffusion disks before use. Disks were added to BSK-II media, GFP-tagged 
B.burgdorferi in was inoculated, and a second layer of BSK-II media was added. Plates were incubated for 
10 days before examination by eye and camera phone (a&d) and by fluorescent imaging on Bio rad chemi-
doc MP fluorescent imaging system at 5532nm excitation/528nm emission.05sec exposure time (b&c).  b. 
Possible zone of inhibition in dotted white outline, c. Representative 6-well plating fluorescent chemi-doc 
image d. Representative white-light plate with fungal growth seen in 2/3/4 (black fungus) and 11/12/13 
(white fungus) wells.   
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 Given my observations from the growth curve, where I saw centrally inoculated GFP-tagged B. 
burgdorferi spread radially in a punctuated but relatively even distribution, forming regularly distributed 
clumped colonies to the edges of the plate, I Therefore, a modification of the classic disk diffusion assay 
containing discs layered between media and using the bacterium’s documented movement pattern to create a 
lawn-alternative was implemented. Disks containing extracts reconstituted at 10x concentration were plated 
between 2 layers of semi-sold BSK-II Borrelia-amended media, with a central inoculation of the pathogen, 
incubated for 10 days in sealed, microaerophilic conditions, and the plates photographed both in room light 
and via fluorescent Bio rad chemi-doc MP fluorescent imaging system at 532nm excitation/528nm emission 
with .05sec exposure time, producing false-color images. 
 Zones of avoidance, represented by interference with normal Borrelia migration and colony seeding 
were expected, and, as seen in figure15 b, c, were observed. The novel semisolid plating was successful as a 
test-of-concept, however the results were confounded by contamination and limited availability of test 
compounds. The issue of contamination was consistent throughout the experiment due to the very rich media 
and long incubation periods. An example of this contamination can be seen by fungal growth in figure 15 d. 
An anti-fungal media recipe which does not inhibit Borrelia has been perfected, and will be used in future 
iterations of this plating method. The black fungus seen in disc 2,3,4 of figure 15 d, however, is an 
interesting result allowed by the untreated media. This black fungus was not observed during extraction, but 

















Counter testing results: 
  
 I chose the 13 most effective water extracts and spotted onto plates containing E.coli MG1655, 
attenuated E.coli WO153, or S.aureus HG003. Zones of inhibition were read by eye, based on antibiotic 
control, using a semi-quantitative 0-3 rating with 3 being antibiotic zone, and zero being no apparent zone of 
inhibition, but only a single extract (nettle) showed inhibition in counter testing. Counter testing was 
inconclusive, showing little inhibition, even from known gram-negative inhibitors like dandelion (10) grown 
in lawn and spotted with 13 best water hits at 10x strength show little inhibition, even from known gram-
negative inhibitors like dandelion (10). 
 Note several dots show microbial growth in the area of extract addition rather than inhibition. 
Because the extracts seemed to have lost action, I did not proceed to HPLC separation and testing. 
Discussion  
 This study sought to use anecdotal treatment success as an initial filter to identify natural products to 
test against B. burgdorferi for specific inhibition. Three extracts of each identified plant material, made using 
water, methanol, and hexanes individually, were exposed to fluorescently tagged B. burgdorferi and allowed 
to grow under conditions optimized for the bacterium.  Bacterial growth was measured via fluorescence (in 
liquid media) and by estimated zones of inhibition (in solid media), and compared to positive and negative 
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controls to quantify changes in growth.  In order to establish specificity, extracts effective in inhibiting B. 
burgdorferi were also exposed to common pathogens S. aureus (gram positive), and E. coli (gram negative) 
in lawn presentation. During the study, several plant sources warranting further investigation were identified, 
and a new method of testing compounds against Borrelia strains was piloted. 
On anecdotal usage- 
 Herbs were an early source of medicine for humans, and persist in their importance to the 
pharmaceutical field. Antibiotic properties, often present in secondary metabolites, are the result of 
evolutionarily successful biological warfare and have become of greater interest as we see microbial 
resistance to previously identified antibiotics increase. Slightly higher than 10% of known plants have been 
used medicinally (Cowan, 1999), so finding an effective filter for choosing what to test is essential. 
Anecdotal success against Lyme disease proved to be just such a filter, providing 80-97% investigable hits 
between inhibitory and growth factors: Twenty nine out of thirty plants demonstrated inhibition of B. 






 The action against B. burgdorferi from these plants was not uniform across solvents, meaning that 
different solvent extracts from the same plant sometimes had contrasting effects on the bacterium. This was 
true of 15 plants, and while such contradictory effects do not interfere with their pharmaceutical usefulness, 
because they can be purified in a lab setting, they could impact whole-plant applications, commonly 
employed in sub-clinical settings. A brief evaluation of cumulative action across the whole plant (summing 
the action of the three tested solvents) (figure 23) however, demonstrates a clear, strong, pattern of B. 
burgdorferi inhibition. While it is important to understand that the physiological effects of these herbs as oral 
treatments may not be cumulative in this way for any number of reasons, including bioavailability, tissue 
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passage, or deactivation by gastric enzymes, it demonstrates the success of using anecdotal Lyme disease 
remedies as a selection filter for compounds with Borrelia inhibition in-vitro. 
 An impressive twelve out of 27 fully tested plant sources showed inhibition of B .burgdorferi growth 
in all three extracts, while one (Uncaria tomentosa, or cat’s claw) was consistently growth-inducing, and 
three plants had incomplete test results due to inability to resuspend extracts after drying (rosemary and 
wormwood) or to intrinsic fluorescence (turmeric) which interfered with data collection.   
 On further investigation of the literature U. tomentosa, shows great promise in chemotherapeutic 
(Almeida et al., 2017) brain-plaque applications (Snow et al., 2019)and (surprisingly) against alternate 
Borrelial morphologies (Weiss, 2018), but its growth acceleration of the motile spirochetal form may 
confound its use. More investigation is needed in this area to understand how the inhibition of morphological 
presentation in Borrelia is linked to the acceleration of another. 
 Scientifically, compounds which enhance Borrelia growth could provide useful information about 
the metabolism of the pathogen, and molecular access pathways that could be accessed or inverted to kill it. 
Knowledge of what accelerates growth may contribute to our understanding of inhibiting growth as well. A 
more proximate use of growth accelerators of B. burgdorferi is to aid in recovering difficult-to-find 
spirochetes from mammalian samples, with a goal of understanding whether PTLDS is a consequence of 
continued spriochetosis ( D’Onofrio,  A. personal communication).  Much further down the drug-
development pipeline, an isolated Borrelia growth-enhancing compound could be used in combination 
therapies. A compound which denied the bacterium the ability to go dormant or form persisters could be a 
powerful treatment tool when administered with a companion antibiotic that kills (as most antibiotics do) 
during the organism’s reproductive cycle.  
 From a biochemical perspective, Borrelia growth acceleration in some fractions will not preclude 
investigation of their inhibiting neighbors, as inhibitory compounds may be chemically identified and 
separated. In a sub-clinical treatment setting, however, findings of cat’s claw U. tomentosa and Dipsacus 
fullonum (commonly known as fullers Teasel) as growth enhancers are potentially very important. These two 
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herbs figure prominently in many of the popular anti-Lyme disease protocols and self-administering patients 
could be unwittingly promoting long-term infection or PTLDS by their use.   
 Entrenchment is a persistent concern with use of herbal remedies against Lyme disease. The list of 
tested anecdotal uses in traditional medicine were researched on several popular herbal databases (figure 24) 
and found to fall into three main categories: antimicrobial, anti-inflammatory, and blood sugar control. This 
is relevant because anecdotal treatment success is necessarily subjective- representing an alleviation of 
symptoms, but perhaps not clearing the infection and allowing the bacterium to become even more deeply 
established. For instance: 
relieving inflammation caused 
by immune reaction to Borrelia 
infection (Grab et al., 2005) 
could provide apparent relief 
while leaving the infection 
intact; or temporary reduction of 
Borrelia population via a strong, 
but short-lived, antibacterial 
compound can reduce bacterial load, and kill important commensal organisms, while leaving persisters to 
replenish the pathogenic population (Sharma et al., 2015); or the lowering of free blood glucose which 
downregulates Borrelia proliferation by signaling stress-induced protective morphologies (Vancova et al, 
2017) could result in a temporary relief of symptoms while leaving the infection intact.  
 
Chemical Considerations: 
 The physical observations of plant products during extraction met with expected results in that water 
extractions were more likely to demonstrate evidence of bacterial growth (film or bubbles). Whether from 
the dried natural products or growth in non-sterile conditions, this makes sense due to the comparatively 
antibacterial action of methanol and hexanes solvents. Bacterial inhabitants of the dried plant products might 
Table 4: traditional medicine uses of chosen anecdotal compounds  
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have been removed by UV sterilizing the materials before extraction, and that may indeed be done in future 
iterations of this research, however the presence of a powerful fungal killer in the andrographis gave the best 
antibacterial results of anything tested, proving an initial test useful.  
 Another extraction consideration in our study is repetition of compounds due to non-sequential 
extraction.  Initial testing involved individual solvent extractions to maximize potential compounds, but 
future studies should perform serial extractions to help purify relevant extracts. Even discounting possible 
overlap of extraction between solvents (methanol could separate some of the same compounds extracted by 
water or hexanes), plants containing efficacy across multiple fractions- like dandelion and nettle, are most 
likely displaying multiple Borrelia-effective compounds, which is in-itself, an exciting finding.  
 Water extracts were more likely to have floating plant material in the form of whole plant (float) or 
particulate suspension (cloudy) (figure 13) which did not seem to be a product of trapped air as it was not 
seen in the less polar solvents. This is likely due to the higher density of water, and the hydrophobic effect on 
more polar plant oils. Methanol drew brighter, clearer colors from the plants, often associated with 
antioxidant compounds and hexanes extracts were usually pale. 
 Water extracts had the most B.burgdorferi  inhibiting compounds, somewhat surprising due to the 
their high polarity, in light of the  (Richter et al., 2017) study. Some of these are easy to corroborate in the 
current literature, for instance: Japanese knotweed has many bioactive compounds and antioxidants and is the 
primary source of resveratrol for commercial supplements (Lachowicz and Oszmianski, 2019), and 
dandelion, chosen for its role in the Borrelia-immune deer diet has had some interesting findings also: (Diaz 
et al., 2018; Kenny et al., 2015). Barberry has action against E.coli and yeast membrane, which makes it an 
interesting candidate for suppressing both the spirochete and round body morphological forms, (Malik et al., 
2017; Zoric et al., 2017), and fennel (Nguyen et al., 2014) joins other oily plant products in being an 
expected inhibitor.  
 Methanol’s best acting extract was one of our known controls, Monolauren, which arrived in pellet 
form and is a byproduct of coconut oil, separated for commercial uses, was predictably insoluble in water, 
but surprisingly partially insoluble in hexanes. This fulfills the necessary characteristic of large amphiphilic 
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moment in (Richter et al., 2017)  and might be expected to affect its ability to access gram negative-like 
double membranes to be increased. Indeed, I found in liquid testing results that methanol solutions of 
monolaurin were very effective inhibitors of B.burgdorferi, and this effect was similar to that observed by 
(Goc et al., 2017). 
 Stevia, another positive control, had mixed action in our study, and the paper which caused it to be 
chosen as a control, (Theophilus et al., 2015) used alcohol extracts of stevia, suspended in their solvent and 
added to a liquid media culture of GFP-tagged B.burgdorferi, while I applied solvent-suspended extracts to 
96 well plates and allowed them to evaporate before application. In this context, the finding of a methanol 
extract of stevia as inhibitory is consistent with current literature. 
 Herbaceous oils generally considered to be anti-bacterial both anecdotally and in literature(Liu et al., 
2017) (Bower et al., 2016; Nguyen et al., 2014) and thus  the inhibition exhibited by rosemary and clove oils 
were expected results, while low action by oregano was unexpected, and garlic- high in sulfur and a 
documented broad spectrum antimicrobial (Van Loi et al., 2019) was notably missing.  
 Hexanes extracts were interesting in their equal distribution between excitatory and inhibitory action, 
I hypothesize that this would have to do with membrane access of nutrients, but it is an area worthy of further 
study.  The stand-out result, which showed near 100% inhibition of B. burgdorferi, and over twice the 
inhibition of the antibiotic control, was the hexanes-hardy volunteer fungus from Andrographis.  Recent 
work by (Roy et al., 2016) identifies a newly documented andrographis-related bacterium with strong 
antimicrobial action Bacillus thuringiensis KL.  Compounds in the plant itself  have also shown promise 
(Arifullah et al., 2013), but the actor in the dish seemed to be the fungal growth, so this is an area that needs 
further exploration. 
Borrelia is tough to grow 
 Much work went into investigating plating and detection methods for Borrelia. Due to the high 
detection threshold (106) of the plate reader (BioTek Synergy H1); loss of fluorescent result resolution past 
log phase due to accumulated free GFP; lack of success with several cell-dyes and markers; and the tendency 
of flow cytometry to shred the spirochetes or clog through spirochetal clumping, alternate detection methods 
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were investigated. Colorimetric agents were added to Borrelia-optimized plating but lacked specificity or 
ability to quantify results.  
 Commonly, pathogenic bacteria are grown in lawn presentation and dotted with antimicrobial 
compounds, then incubated and checked for zones of inhibition. However, due to Borrelia’s inter-media 
growth preference, migratory rather than creeping growth morphology, and colony-clumping growth 
behavior, traditional lawn presentation and dotting is not successful. Observations of GFP-tagged B. 
burgdorferi growth pattern on solid media led to development of Borrelia lawn-alternative, or novel semi-
solid plating. In growth curve plating, GFP-tagged B. burgdorferi placed in the center of a plate was 
observed to migrate to the outer edges leaving spotty, but relatively uniform coverage throughout the media.  
Capitalizing on its pattern of migration, the idea of embedding test extracts within the semi-solid media was 
implemented. In order to allow presentation of the extract independent of the antimicrobial solvents 
(methanol and hexanes), paper inhibition discs were used. (Water extracts were not tested in this way due to 
lack of access.)  
 The pilot of this plating system was a qualified success, demonstrating avoidance zones around 
several extracts, and further optimization is in order. Committee member Dr. Vanja Klepac-Ceraj suggested 
adding Borrelia to the top plating layer to demonstrate true inhibition. While the theory is sound, 
implementation may be difficult due to the agarose/serum additives to the semi-solid agar which must remain 
hot until pouring and cannot be re-heated to liquefy without denaturing the blood additive.  
 Another stumbling block was the richness of the media. Borrelia- optimized media and long 
cultivation times make opportunistic microbial growth a constant difficulty. Contamination issues plagued 
both the growth curve and the novel semi-solid plating method inspired by it- causing loss of almost all FlaB 
non-motile mutant B. burgdorferi growth curve results, day 9&10 of GFP-tagged B. burgdorferi growth 
curve results, and many of the semi-lawn plating results impossible to read. An antifungal/antibacterial 
additive recipe that does not interfere with Borrelia growth would be a necessary additive to the lawn-
alternative plating approach. 
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 One of the primary goals of this study was compound specificity to Borrelia, and the counter screen 
directed at establishing specificity demonstrated very little action against common gram positive and gram 
negative pathogens.  While this might have been interpreted as specificity, the tested compounds included 
several known to have action against E. coli and S. aureus, for instance 10 (Diaz et al., 2018; Kenny et al., 
2015) dandelion, and these were among those which failed to show zones of inhibition. This finding cause 
the screen to be invalidated, and was interpreted as loss of action due to the multi-month gap between 
resuspension and counter testing. In future iterations, ideally, counter testing would be completed at the time 
of Borrelia testing.  
 To pursue the findings of this study, future sequential multi-solvent extractions and separation by 
characteristics such as polarity and size, using resins, liquid-liquid extraction, addition of proteinaseK, and 
other known methods of purification should be employed on the tope hits: from water- both the strong 
inhibitory hits of dandelion, nettle, barberry, fennel, Japanese knotweed, and neem from water extraction, 
and the growth hits: fuller’s teasel and cat’s claw. The andrographis fungus should also be investigated.  
 The resulting purifications should be re-tested against the original pathogen-set to isolate active 
compounds and isolated using High Performance Liquid Chromatography (HPLC) followed by fractional 
bioassays. Liquid Chromatography Mass Spectrometry (LCMS) should be used to establish novel mass, and 
Nuclear Magnetic Resonance (NMR) to elucidate structure of the thus-identified active compounds, and the 
compounds should be tested for general toxicity, hemolytic effect, and evaluated for MIC before 
administering to mouse models for in-vivo efficacy.  
 Long-term studies could continue to characterize our discovered compounds against multiple Borrelia 
strains, looking for phylogenic and evolutionary clues to fighting the pathogen, and differential effects that 
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